Kurs
0,00%
Kurs
0,00%
Kalender
| Est. tid* | ||
| 2020-11-20 | - | Extra Bolagsstämma |
| 2015-12-09 | - | 15-6 2015 |
| 2015-09-21 | - | Extra Bolagsstämma 2015 |
| 2014-11-27 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-28 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-22 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-27 | - | Bokslutskommuniké 2013 |
| 2013-11-28 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-28 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-11 | - | Årsstämma |
| 2013-05-21 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-12 | - | Extra Bolagsstämma 2013 |
| 2013-02-28 | - | Bokslutskommuniké 2012 |
| 2012-11-28 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-28 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-14 | - | Årsstämma |
| 2012-05-30 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-28 | - | Bokslutskommuniké 2011 |
| 2011-11-22 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-31 | - | Kvartalsrapport 2011-Q2 |
| 2011-06-15 | - | Årsstämma |
| 2011-05-31 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-28 | - | Bokslutskommuniké 2010 |
2020-10-06 11:41:09
Immunopharma AS has, through its 100 % owned subsidiary Nordic Healthy Living AS, purchased 13.169.429 shares from the second largest owner in Eqology AS, BGConsult AS controlled by Børre Gjersvik and 4.500.000 shares from 4th largest shareholder in Eqology AS, Momentum Consult & Invest AS controlled by Robert Heldal. The purchase price is 1 NOK per share in Eqology AS and the majority part of the purchase is converted to shares in Immunopharma AS at a price of 4,50 NOK per share in Immunopharma AS.
After these purchases, Immunopharma AS indirectly controls 69,8 % of the shares in Eqology AS through its wholly owned subsidiary Nordic Healthy Living AS.
For questions, contact:
Roar Arnstad
CEO
E-mail: roar.arnstad@eqology.no
Christian Espeseth
Chairman of the board